DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Lawitz E, Poordad F, Brainard D et al.
Sofosbuvir in combination with PEG-IFN and ribavirin for 12 weeks provides high SVR rates in HCV infected genotype 2 or 3 treatment-experienced patients with and without compensated cirrhosis: results from the Lonestar-2 study.
Hepatology 2013;
58: LB-4
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.